SCHEMBL25249173

SCHEMBL25249173

NC(=O)C=Cc1cc2c(Nc3ccnc(-c4ccccc4F)c3)ncnc2cc1OCCCN1CCOCC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 15/20 0.54
ERBB2 P04626 7/20 0.52
SRC P12931 4/20 0.52
ERBB4 Q15303 4/20 0.52
HDAC1 Q13547 3/20 0.52
LCK P06239 3/20 0.52
RET P07949 3/20 0.52
MET P08581 3/20 0.52
LTK P29376 3/20 0.52
KDR P35968 3/20 0.52
MAP4K5 Q9Y4K4 3/20 0.52
KIT P10721 3/20 0.52
ERBB3 P21860 3/20 0.52
AURKB Q96GD4 3/20 0.52
HDAC3 O15379 2/20 0.52
HDAC6 Q9UBN7 2/20 0.52
FYN P06241 2/20 0.52
PDGFRA P16234 2/20 0.52
MAP2K2 P36507 2/20 0.52
MAP2K1 Q02750 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3246210 0.85 HDAC1 (0.60) EGFRERBB2SRCHDAC1LCK
Hydrochloric Acid SCHEMBL2052117 0.84 EGFR (0.71) EGFRERBB2SRCERBB4LCK
SCHEMBL25370207 0.84 EGFR (0.73) EGFRERBB2SRCERBB4LCK
SCHEMBL3240234 0.83 EGFR (0.70) EGFRERBB2SRCHDAC1KDR
SCHEMBL25244132 0.83 EGFR (0.53) EGFRERBB2KDRAURKBPDGFRB
SCHEMBL25369245 0.81 EGFR (0.68) EGFRERBB2SRCERBB4LCK
SCHEMBL25267376 0.80 EGFR (0.45) EGFRERBB2ERBB4KDRAURKB
Hydrochloric Acid SCHEMBL2052116 0.80 EGFR (0.69) EGFRERBB2SRCERBB4LCK
SCHEMBL26056425 0.80 EGFR (0.64) EGFRERBB2SRCERBB4LCK
SCHEMBL26055503 0.78 EGFR (0.52) EGFRERBB2SRCERBB4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4194443-A1 EFGR INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF Abbisko Therapeutics Co., Ltd. (CN) 2023-06-14 EP disclosed